FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

NATCO Pharma Lansoprazole Delayed-Release Capsules Recall

Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent…

NATCO Pharma Limited · Rangareddy, N/A

Risk level
Class II
Reported by FDA
Apr 17, 2024
Recall ID
D-0438-2024
Check your lot numberHow we source this data

Summary

NATCO Pharma recalled Lansoprazole Delayed-Release Capsules starting Mar 27, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0438-2024 on Apr 17, 2024. Reason: CGMP Deviations. Status: Terminated.

Why it was recalled

CGMP Deviations

Product description

Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41

Lot numbers, UPCs & expiration codes

Lot#: 411988, Exp date: 05/31/2025

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0438-2024
Classification
Class II
Status
Terminated
Recall initiated
Mar 27, 2024
FDA report date
Apr 17, 2024
Quantity
30 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
NATCO Pharma Limited

Original FDA data

Every field from FDA enforcement report D-0438-2024, exactly as published.

Show all FDA fields
City
Rangareddy
Status
Terminated
Country
India
Event ID
94296
Address
Pharma Division, Kothur Village
Code information
Lot#: 411988, Exp date: 05/31/2025
Report date
Apr 17, 2024
Product type
Drugs
Recall number
D-0438-2024
Classification
Class II
Recalling firm
NATCO Pharma Limited
Product quantity
30 bottles
Termination date
Feb 6, 2026
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
Distribution pattern
Nationwide in the US
Recall initiation date
Mar 27, 2024
Initial firm notification
Letter
Center classification date
Apr 5, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0438-2024, published Apr 17, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls